Automated insulin infusion trials in the intensive care unit.
The objective is to demonstrate the effectiveness of a simple automated insulin infusion for controlling the rise and duration of blood glucose excursion following a glucose challenge in critically ill patients with impaired glucose tolerance. A two-compartment model of the glucose regulatory system was developed for intravenous infusion control design. On two subsequent days a critically ill patient with impaired glucose tolerance was given a 75 g oral glucose tolerance test (OGTT), and the glucose level was measured every 15 min. The first day's data were used to design a heavy-derivative insulin infusion controller for the second day. Ethics approval was granted for this test. Five patients were studied. In four patients, the magnitude and duration of blood glucose excursion were reduced over 50%. Fasting level was reduced 15%, from an average of 7.2 mmol/L to 6.1 mmol/L. The fifth patient's results showed a diminished response due to the antagonistic effects of hydrocortisone on insulin, a data point not provided prior to testing. Modeling to account for this effect yielded better correlation with the test. The automated algorithm provided rapid, effective control of the blood glucose rise in response to an OGTT input. These results highlight the effectiveness of automated infusions for regulating blood glucose rise and excursions, and the potential of this approach for non-hospitalized individuals.
Doran
Carmen V
CV
Department of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand. c.doran@mech.canterbury.ac.nz
Chase
J Geoffrey
JG
Shaw
Geoffrey M
GM
Moorhead
Katherine T
KT
Hudson
Nicolas H
NH
D001331:Automation / Q000379:methods; D001786:Blood Glucose / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy; D005951:Glucose Tolerance Test; D006801:Humans; D007332:Insulin Infusion Systems; D007362:Intensive Care Units
D001786:Blood Glucose